Transforming the fragmented silos of medicine into a wheel of collaboration holds the key to tackling complex health challenges for generations to come.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kern, L. M., Bynum, J. P. W. & Pincus, H. A. JAMA Intern. Med. 184, 236–237 (2024).
Barnett, M. L., Bitton, A., Souza, J. & Landon, B. E. Ann. Intern. Med. 174, 1658–1665 (2021).
Subbiah, V. Nat. Med. 29, 49–58 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author reports no competing interests relevant to this publication, as the content is solely the personal viewpoint of the author. The author reports consulting or advisory roles (paid to institution) from Abbvie, Astex Pharmaceuticals, AstraZeneca, Bayer, Genmab, Incyte, Lilly/Loxo Oncology, Novartis, Obsidian Therapeutics, Pfizer, Pheon Therapeutics, Regeneron, Relay Therapeutics and Roche; and other consulting or advisory roles from Jazz Pharmaceuticals, Incyte, Loxo Oncology /Lilly, Novartis, Relay Therapeutics, Daiichi Sankyo, Illumina and Bayer, and continuing medical education funds from Medscape, OncLive, Clinical Care Communications, PERS and Med Learning Group.
Rights and permissions
About this article
Cite this article
Subbiah, V. Fragmentation in medicine harms patients and hinders research. Nat Med 30, 2394 (2024). https://doi.org/10.1038/s41591-024-03194-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-024-03194-1
